Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | 66.11 | 5.35 | 68.50 | 91.12 |
Depreciation/ Depletion | 31.52 | 32.13 | 32.15 | 22.28 |
Non- Cash Items | 22.45 | 20.86 | 13.79 | 5.48 |
Changesin Working Capital | -69.95 | -35.89 | -74.20 | -28.42 |
Cashfrom Operating Activities | 50.12 | 22.45 | 40.23 | 90.45 |
Capital Expenditures | -52.16 | -29.92 | -27.25 | -151.75 |
Other Investing Cash Flow Items Total | 0.09 | 0.23 | 0.09 | 0.16 |
Cashfrom Investing Activities | -52.07 | -29.69 | -27.15 | -151.59 |
Financing Cash Flow Items | -21.75 | -20.93 | -13.79 | -6.14 |
Total Cash Dividends Paid | -2.54 | -2.54 | -2.54 | - |
Issuance( Retirement)of Stock Net | 28.48 | - | - | - |
Issuance( Retirement)of Debt Net | 26.49 | -8.50 | 9.41 | 98.16 |
Cashfrom Financing Activities | 30.68 | -31.97 | -6.92 | 92.02 |
Net Changein Cash | 28.73 | -39.21 | 6.16 | 30.88 |
Cash Interest Paid | 21.75 | 20.93 | 13.79 | 6.14 |
Cash Taxes Paid | 15.40 | 4.60 | 14.92 | 16.05 |
SMS Pharmaceuticals Dividend SMS Pharmaceuticals Bonus SMS Pharmaceuticals News SMS Pharmaceuticals AGM SMS Pharmaceuticals Rights SMS Pharmaceuticals Splits SMS Pharmaceuticals Board Meetings SMS Pharmaceuticals Key Metrics SMS Pharmaceuticals Shareholdings SMS Pharmaceuticals Profit Loss SMS Pharmaceuticals Balance Sheet SMS Pharmaceuticals Q1 Results SMS Pharmaceuticals Q2 Results SMS Pharmaceuticals Q3 Results SMS Pharmaceuticals Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks